Robert Thomas
Vermögen: 4 Mio $ am 31.05.2026
Vermögen: 4 Mio $ am 31.05.2026
Robert Bain Thomas is Chairman at Starpharma Holdings Ltd. since 2014.
Chairman at State Library of New South Wales Foundation.
Chairman at Grahger Retail Securities Pty Ltd. Non-Executive Director at O'Connell Street Associates Pty Ltd. since 2011.
Member of Securities Institute of Australia since 1976.
Member of Stockbrokers Association of Australia.
President of Library Council of NSW.
Former CEO-Corporate & Investment Bank at Smith Barney Asset Management from 1999 to 2003.
Former Chief Executive Officer at Salomon Smith Barney New Zealand Ltd. from 1999 to 2003.
Former Chief Executive Officer at Salomon Smith Barney Australia Pty Ltd. from 1999 to 2003.
Former Chief Executive Officer & Head-Research at UBS Wealth Management Australia Ltd. Former Chairman & Chief Executive Officer at Citigroup Australia Pty Ltd. Former Chief Executive Officer at County Natwest Securities Australia Pty Ltd. Non-Executive Chairman at Australian Wealth Management Ltd. from 2005 to 2007.
Chairman at United Funds Management Ltd. Chairman-Global Corporate & Investment Bank at Citigroup Global Markets Australia Pty Ltd. from 2003 to 2004.
Chairman at TAL Ltd. from 2007 to 2014.
Chairman at State Library of New South Wales.
Chairman at Virgin Australia International Airlines Pty Ltd. Chairman at Grahger Capital Securities Pty Ltd. from 2014 to 2020.
Chairman at Citibank Ltd. Non-Executive Director at Heartware Pty Ltd. Independent Non-Executive Director at Virgin Australia Holdings Ltd. from 2011 to 2018.
Independent Director at REVA Medical, Inc. Independent Non-Executive Director at Biotron Ltd. from 2012 to 2026.
Independent Non-Executive Director at HeartWare International LLC from 2013 to 2016.
Director at Aus Bio Ltd. Lead Non-Executive Independent Director at Clarity Pharmaceuticals Ltd. from 2022 to 2024.
Education includes an undergraduate degree from Monash University conferred in 1966.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 1’175’000 ( 0.32% ) | 2 Mio $ | 31.05.2026 | |
| 16.10.2025 | 3’500’000 ( 0.83% ) | 2 Mio $ | 31.05.2026 | |
BIOTRON LIMITED 0.41% | 06.02.2026 | 11’200’000 ( 0.41% ) | 16 128 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Vorsitzender | 13.06.2014 |
Library Council of NSW | Präsident | 19.01.2011 |
State Library of New South Wales Foundation | Vorsitzender | - |
Grahger Retail Securities Pty Ltd. | Vorsitzender | - |
O'Connell Street Associates Pty Ltd.
O'Connell Street Associates Pty Ltd. Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | - |
Stockbrokers Association of Australia
Stockbrokers Association of Australia Miscellaneous Commercial ServicesCommercial Services Operates stock brokers association | Corporate Officer/Principal | - |
Securities Institute of Australia
Securities Institute of Australia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1976 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOTRON LIMITED | Direktor/Vorstandsmitglied | 06.02.2026 |
| CLARITY PHARMACEUTICALS LTD | Direktor/Vorstandsmitglied | 23.08.2024 |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 29 |
|---|---|
Biotron Ltd.
Biotron Ltd. BiotechnologyHealth Technology Operates as a biotechnology research and development company that manufactures anti-viral drugs | Health Technology |
Heartware Pty Ltd.
Heartware Pty Ltd. Medical SpecialtiesHealth Technology Develops & manufactures implantable circulatory assist devices | Health Technology |
Smith Barney Asset Management
Smith Barney Asset Management Investment ManagersFinance Provides investment services | Finance |
Starpharma Holdings Ltd.
Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Salomon Smith Barney New Zealand Ltd. | |
Salomon Smith Barney Australia Pty Ltd.
Salomon Smith Barney Australia Pty Ltd. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Virgin Australia Holdings Pty Ltd.
Virgin Australia Holdings Pty Ltd. AirlinesTransportation Operates as a holding company with interests in providing domestic and international airline services | Transportation |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Wealth Management Ltd.
Australian Wealth Management Ltd. Investment ManagersFinance Provides wealth management and advisory services | Finance |
Securities Institute of Australia
Securities Institute of Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
United Funds Management Ltd.
United Funds Management Ltd. Investment ManagersFinance United is an active multi-manager which provides investors with access to a range of 'blended' portfolios of leading fund managers in each asset class, aiming to provide above median performance at below median risk. The firm's in-house Investment Team determines strategic and tactical asset allocation against predetermined benchmarks and selects fund managers based on their investment style and process, consistency in applying their investment style and process, proficiency and experience of their investment team, past performance, potential to add value over the long-term and their risk/management controls. United selects investment managers with complementary styles for each asset class to reduce style or capitalization bias. For each of their diversified funds, they employ a passive asset allocation approach based on the relevant average asset allocation of the respective universe, focusing on stock selection as the key source of out-performance. | Finance |
REVA Medical, Inc.
REVA Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells implantable bio resorbable medical devices | Health Technology |
Citigroup Global Markets Australia Pty Ltd.
Citigroup Global Markets Australia Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
UBS Wealth Management Australia Ltd.
UBS Wealth Management Australia Ltd. Investment ManagersFinance Provides wealth management services | Finance |
TAL Ltd.
TAL Ltd. Life/Health InsuranceFinance Provides life insurance, risk, superannuation and retirement solutions | Finance |
Citibank Ltd.
Citibank Ltd. Major BanksFinance Operates a bank and provides financial services | Finance |
HeartWare International LLC
HeartWare International LLC Medical SpecialtiesHealth Technology Develops and manufactures implantable heart pumps | Health Technology |
Citigroup Australia Pty Ltd.
Citigroup Australia Pty Ltd. Regional BanksFinance Operates as a state chartered commercial bank | Finance |
Stockbrokers Association of Australia
Stockbrokers Association of Australia Miscellaneous Commercial ServicesCommercial Services Operates stock brokers association | Commercial Services |
State Library of New South Wales | Government |
County Natwest Securities Australia Pty Ltd. | |
O'Connell Street Associates Pty Ltd.
O'Connell Street Associates Pty Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Grahger Capital Securities Pty Ltd. | |
Aus Bio Ltd.
Aus Bio Ltd. BiotechnologyHealth Technology Operates as a research and development biotechnology company | Health Technology |
Library Council of NSW | |
Virgin Australia International Airlines Pty Ltd.
Virgin Australia International Airlines Pty Ltd. AirlinesTransportation Provides commercial airline services | Transportation |
State Library of New South Wales Foundation | |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Grahger Retail Securities Pty Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen